What does CUSIP 45782T105 represent in this 13F holders report?

CUSIP 45782T105 is the security identifier for INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

How many institutions held INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in Q4 2019?

9 institutional investors reported INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share for Q4 2019. Use the holders table for investor-level position and value details.

Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

CUSIP: 45782T105

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 27,969,231
Total 13F shares: 282,367
Share change: +7,129
Total reported value: $1,637,000
Price per share: $5.80
Number of holders: 9
Value change: +$40,401
Number of buys: 4
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2020
Previous quarter: Q3 2019

Recent filing periods for CUSIP 45782T105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Financial Advocates Investment Management	13F	Company	0.8%	224,667	$1,326,000	—	30 Sep 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.15%	41,333	$243,000	—	30 Sep 2019	13F
BlackRock Finance, Inc.	13F	Company	0.01%	3,955	$24,000	—	30 Sep 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	1,700	$10,000	—	30 Sep 2019	13F
Covington Capital Management	13F	Company	0%	1,000	$6,000	—	30 Sep 2019	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0%	843	$5,000	—	30 Sep 2019	13F
UBS Group AG	13F	Company	0%	636	$4,000	—	30 Sep 2019	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	204	$1,000	—	30 Sep 2019	13F
Advisor Group, Inc.	13F	Company	0%	200	$1,000	—	30 Sep 2019	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0%	100	$1,000	—	30 Sep 2019	13F

Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q4 2019

As of 31 Dec 2019, Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 282,367 shares. The largest 9 holders included Financial Advocates Investment Management, DEUTSCHE BANK AG\, BlackRock Inc., BANK OF AMERICA CORP /DE/, TRUE Private Wealth Advisors, Covington Capital Management, Retirement Group, LLC, Advisory Services Network, LLC, and Advisor Group, Inc.. This page lists 9 institutional shareholders reporting positions in this security for the Q4 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

Q4 2019 holders

Holder diff

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 Value $	Q4 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.